Stargardt Disease Clinical Trials in Aurora, Colorado

3 studies are recruiting for stargardt disease in Aurora, Colorado right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Study of ALK-001 on the Progression of Stargardt Disease

    This study evaluates the efficacy and safety of investigational study drug ALK-001 in participants 8 to 45 years of age, inclusive, with symptoms and signs of autosomal recessive Stargardt disease (STGD)

    Stage
    Phase 3
    Ages
    8 to 45
    Site
    University of Colorado SOM, Sue-Anschutz-Rodgers Eye Center, Aurora, Colorado
    Locations
    14 in total
    Run by
    Alkeus Pharmaceuticals, Inc.

    See if you can join NCT07419334 on ClinicalTrials.gov

  2. An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene

    This is an Observational Study to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene This is a multicenter study which will enroll approximately 75 subjects

    Stage
    Not phased
    Ages
    12 to 65
    Site
    UCHealth Sue Anschutz-Rodgers Eye Center, Aurora, Colorado
    Locations
    20 in total
    Run by
    Splice Bio

    See if you can join NCT06435000 on ClinicalTrials.gov

  3. A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)

    This Phase 1/2 study will evaluate the safety, tolerability, and preliminary efficacy of subretinal SB-007 administration to determine dose selection in subjects with Stargardt's Type 1 (STGD1). This is a multicenter study which will enroll approximately 57 subjects, followed up over a 96 week peri…

    Stage
    Phase 1
    Ages
    12 to 65
    Site
    UCHealth Sue Anschutz-Rodgers Eye Center,, Aurora, Colorado
    Locations
    5 in total
    Run by
    Splice Bio

    See if you can join NCT06942572 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.